New approaches to inhibition of activity of HIV integrase [ 2011-03-04 - 2013-06-30 ]

Research Grant

Researchers: Dr David Chalmers (Chief Investigator) ,  Martin Scanlon (Chief Investigator) ,  Martin Scanlon (Chief Investigator) ,  Dr David Rhodes (Partner Investigator) ,  Dr John Deadman (Partner Investigator)
View all 6 related researchers

Brief description New approaches to inhibition of activity of HIV integrase. This project aims to assist in the development of novel anti-HIV drugs that will benefit the 17000 Australians and more than 33 million people worldwide who are currently suffering with this terrible disease. The project will utilise state-of-the-art approaches in structure-based drug design to identify and synthesise compounds as leads for the development of anti-HIV drugs. Furthermore, the project will provide invaluable training for the researchers involved and enhance the relationship between the academic and commercial collaborators.

Funding Amount $600,000

Funding Scheme Linkage Projects

View this grant in the ARC Data Portal